By categorizing breast cancer cell lines into Luminal A, Luminal B, Luminal-HER2, HER2+, and TNBC, the investigator can be very precise when analyzing data and creating experiments to make novel advancements in science. This evidence concerns the gene ERBB2 and breast carcinoma.